Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Dec 13.
Published in final edited form as: Rapid Commun Mass Spectrom. 2011 Sep 30;25(18):2627–2632. doi: 10.1002/rcm.5162

Unexpected linear ion trap collision-induced dissociation and Fourier transform ion cyclotron resonance infrared multi-photon dissociation fragmentation of a hydrated C-glycoside of 5-fluorouridine formed by the action of the pseudouridine synthases RluA and TruB

Edward J Miracco 1, Bogdan Bogdanov 2, Eugene G Mueller 3,*
PMCID: PMC5728650  NIHMSID: NIHMS920686  PMID: 23657957

Abstract

As part of the investigation of the pseudouridine synthases, 5-fluorouridine in RNA was employed as a mechanistic probe. The hydrated, rearranged product of 5-fluorouridine was isolated as part of a dinucleotide and found to undergo unusual fragmentation during mass spectrometry, with the facile loss of HNCO from the product pyrimidine ring favored over phosphodiester bond rupture. Although the loss of HNCO from uridine and pseudouridine is well established, the pericyclic process leading to their fragmentation cannot operate with the saturated pyrimidine ring in the product of 5-fluorouridine. Based on the MSn results and calculations reported here, a new mechanism relying on the peculiar disposition of the functional groups of the product pyrimidine ring is proposed to account for the unusually facile fragmentation.


The isomerization of uridine to pseudouridine (Ψ) is the most common post-transcriptional modification of RNA and is carried out by the pseudouridine synthase (ΨS) superfamily of enzymes.[1,2] This internal transglycosylation occurs by breaking the C1′–N1 glycosidic bond of uridine, rotation of the free nucleobase, and reattachment to form a C1′–C5 bond (Fig. 1). To elucidate the chemical mechanism, various ΨS have been incubated with RNA in which the reactive uridine has been replaced by 5-fluorouridine (F5U).[37] The F5U is isomerized to the C-glycoside and hydrated at C6;[5,8] additionally, C2′ of F5U suffers epimerization so that two products are formed (Fig. 2).[9] Because MS cannot distinguish these isomeric products and the site of difference is left intact by the unusual fragmentation described below, the products of F5U will be abbreviated simply as F5U*.a

Figure 1.

Figure 1

The conversion of uridine into pseudouridine (Ψ) by pseudouridine synthases (ΨS).

Figure 2.

Figure 2

When the pseudouridine synthases TruB and RluA are incubated with substrate RNA containing F5U in place of the reactive uridine, two rearranged and hydrated products (F5U*) form; they differ in stereochemistry at C2′.[9] F5U* is isolated as part of a dinucleotide with the trailing nucleoside in the RNA because S1 nuclease cannot cut after nonplanar nucleobases.[7]

The F5U* is isolated by digesting the modified RNA with S1 nuclease and alkaline phosphatase followed by preparatory scale reversed-phase high-performance liquid chromatography (HPLC); F5U* is isolated as the 5′-component of a dinucleotide with the nucleoside (C in the TruB substrate, U in the RluA substrate) following F5U, which was confirmed by mass spectrometry (MS) and nuclear magnetic resonance (NMR).[7] Typical fragmentations of canonical nucleotides involve depyrimidination, depurination, or phosphodiester cleavage,[10] but discrete fragmentations of the F5U* nucleobase account for most of the ions detected (Fig. 3(a)). Especially interesting is the apparently unprecedented loss of a neutral HNCO (43 Da) before phosphodiester cleavage. Although the loss of neutral HNCO from pyrimidine rings is common[11,12] and was reported in the original MS characterization of uridine and pseudouridine,[1318] they lose HCNO in a pericyclic mechanism (retro-Diels-Alder reaction) that cannot operate in the case of F5U*. Tandem mass spectrometry experiments complemented with quantum chemical calculations were employed to investigate this unusually facile loss of HCNO from a nucleobase and the mechanism giving rise to it.

Figure 3.

Figure 3

The linear ion trap mass spectra of the F5U* dinucleotide: (a) prior to isolation, CID or IRMPD and (b) after isolation of 585 m/z and CID fragmentation at 13% NCE for 30 ms and a q of 0.25. * peaks not present in the solvent or readily deduced by likely fragmentation.

EXPERIMENTAL

General

RluA and TruB were overexpressed and purified from E. coli as described previously.[1921] The anti-codon stem-loop (ASL) from E. coli tRNAPhe and the T-arm stem-loop (TSL) from S. cerevisiae containing 5-fluorourudine (F5U) in place of the reactive uridine ([F5U]ASL, GGGGAF5UUGAAAAUCCCC; [F5U]TSL, CUGUGUF5U CGAUCCACAG) were purchased from Dharmacon, Inc. (Lafayette, CO, USA) and deprotected according to the manufacturer’s instructions. All experiments were performed with water (≥18.2 MΩ) from a Milli-Q Synthesis system (Millipore, Billerica, MA, USA).

Sample preparation

Samples of product dinucleotides were generated as described in detail elsewhere.[7] Briefly, RluA (200 μM) and [F5U]RNA (150 μM) were incubated at 37 °C for 3 h in 50 mM HEPES buffer (1.6 mL), pH 7.5, containing ammonium chloride (100 mM), dithiothreitol (5 mM), and EDTA (1 mM). The resulting stoichiometric protein-RNA adduct was purified by ion-exchange chromatography and then disrupted by heating. Precipitated RluA was pelleted by centrifugation, and the free RNA (in the supernatant) was digested and dephosphorylated by the addition of S1 nuclease and calf intestine alkaline phosphatase. The resulting dinucleotide products were purified by isocratic reversed-phase HPLC over a preparatory C18 column. Product-bearing fractions were combined, taken to dryness in vacuo, and redissolved. A small aliquot (1.2 μL) was diluted (to ~10 μM) into methanol (50%; Optima* LC/MS grade, Fisher Scientific, Pittsburgh, PA, USA) for MS analysis. The dinucleotide products from the action of TruB (10 μM) on [F5U]TSL (100 μM) were prepared similarly except for the omission of the ion-exchange chromatography and heat disruption since TruB and [F5U]TSL do not form a stable adduct.[5]

Mass spectrometry experiments

All mass spectrometry (MS) and tandem MS (MSn) experiments were performed on a Thermo Finnigan (Bremen, Germany) linear trap quadrupole (LTQ) Fourier transform (FT) mass spectrometer equipped with a Triversa NanoMate (Advion, Ithaca, NY, USA) direct infusion nano-electrospray ionization (nESI) ion source in the negative ion mode. For collision-induced dissociation (CID) MSn (n = 2–6) experiments, the ions of interest were isolated in the LTQ using an isolation window of 1 m/z and subjected to on-resonance CID using helium as the collision gas (it also functions as a bath gas inside the ion trap) using a variable normalized collision energy (NCE) (10–15%) at a constant CID collision time (30 ms) or at a variable CID time (13–50 ms) at a constant NCE (13%), with both methods utilizing a collision q-value of 0.25. For infrared multi-photon dissociation (IRMPD) pseudo-MSn experiments, the [M–H] precursor anions of interest were isolated in the LTQ using an isolation window of 7 m/z, transferred to the ICR cell and subjected to continuous-wave CO2 laser IR light (4 W (20%), 943.40 ± 0.33 cm−1) of variable irradiation times (10–550 ms, after a 20 ms delay after ion trapping) prior to FT-ICR excitation and detection.

Density functional theory (DFT) calculations

Geometric optimization, single point energy, and vibrational frequency calculations on selected ionic and neutral fragment structures were carried out in vacuo using Gaussian 09 IBM64-G09RevA.02 on 8 IBM PowerPC 4.7 GHz processors running AIX 6.1 at the B3LYP/6-311+G(d,p)//AM1 level of theory using facilities at the Center for Research Computing of the University of Louisville.

RESULTS AND DISCUSSION

Linear ion trap CID fragmentation tandem mass spectrometry

During the initial FT-ICR MS accurate mass characterization of the dinucleotide products, fragmentation was observed without deliberate activation of the precursor anion with collision gas, also known as in-source fragmentation (Fig. 3(a)). After performing ion source and transfer optics tuning with the LTQ for the [M–H] precursor anions (585 m/z), ~5% residual fragmentation was still observed that indicated the saturated and hydrated F5U* was an excellent target for an informative MSn analysis. A typical linear ion trap CID MS/MS spectrum of the 585 m/z (Fig. 3(b)) shows the product of HNCO loss (542 m/z) more prominently than the expected predominant species from phosphodiester bond cleavage (341 m/z).

Breakdown curves for the 585 m/z anions (Fig. 4) clearly show that the loss of HNCO (542 m/z) is more favorable than the usually preferred cleavage of the phosphodiester bond (341 m/z) under different CID conditions. Using the standard CID MS/MS setting (CID time = 30 ms and q = 0.25) causes an abrupt onset of the fragmentation at 12% NCE, and by 14% NCE all precursor anions have been fragmented (Fig. 4(a)). Breakdown curves obtained at 13% NCE with varied CID times (Fig. 4(b)) were smoother, and the normalized ion intensity of the ions at 542 m/z leveled off around 60% as opposed to around 70% with varied NCE. For both processes, the onsets are fairly similar, which suggests the transition state energies for both processes are also similar.

Figure 4.

Figure 4

The breakdown curves for the parent dinucleotide after CID fragmentation: (a) varying collision NCE (10–15%) at constant irradiation time (30 ms) and (b) varying collision irradiation time (13–50 ms) at constant NCE (13%).

The ‘ion tree’ of the linear ion trap CID MSn experiments (Supplementary Fig. S1 and Table S1, see Supporting Information) reveals the extensive and diverse fragmentation of this novel nucleoside. A detailed discussion of all fragmentation patterns and ion structures exceeds the scope of this communication, but several points demand attention. After the loss of one HNCO molecule, a second one is lost from 542 m/z in the CID MS3 stage to afford a species at 499 m/z, but this second loss of HCNO is less favorable than phosphodiester bond rupture, which affords the species at 298 m/z. The breakdown curves for MS3 of the anions of 542 m/z (Fig. 5) reveal that both cleavage of the phosphodiester bond and loss of a second HNCO occur with lower energy of fragmentation than similar processes in the anions of 585 m/z. In CID MS4, the anion at 499 m/z loses HF and other neutrals.

Figure 5.

Figure 5

The isolated fragment ion after the first HNCO loss (542 m/z) is subjected to varying CID irradiation time (10–100 ms) at constant NCE (13%).

Fourier transform ion cyclotron resonance infrared multi-photon dissociation tandem mass spectrometry

The LTQ-FT offers the option of performing CID experiments and then transferring the remaining precursor ions and the fragment ions to the ICR cell for high-resolving power and high mass measurement accuracy detection. This allows for the discovery of elemental compositions of fragment ions and thus lends additional support for the fragmentation mechanism proposed on the basis of the ion trap CID MSn data. After MS2, however, the ion intensities for the fragment ions become very low; additionally, the 1/3 low-mass cut-off associated with ion trap CID prevents the detection of low m/z fragment ions.

IRMPD in the ICR cell offers the opportunity to fine-tune the fragmentation by controlling the laser energy and irradiation time. In general, IRMPD only samples the lowest energy pathways while delivering pseudo-MSn data because the fragment ions themselves can absorb IR photons until they fragment to afford the next generation of ions. The FT-ICR IRMPD MS spectrum (Fig. 6) shows the loss of HNCO under these conditions still remains more favorable than cleavage of the phosphodiester bond, even at the lowest non-zero laser energy setting and the minimal irradiation time sufficient to induce and detect fragment anions. FT-ICR IRMPD MSn breakdown curves (Supplementary Fig. S2, see Supporting Information) confirm the proposed anion structures deduced from the ion trap CID MSn data and show that all anions eventually fragment to yield H2PO4-, and, ultimately, PO3-.

Figure 6.

Figure 6

After isolation and passage into the ICR cell, the lowest non-zero laser energy still favors HNCO loss over phosphodiester cleavage.

Mechanisms for HNCO loss

The facile loss of neutral HNCO is interesting by itself because the established retro-Diels-Alder mechanism for the same fragmentation in uridine and pseudouridine cannot apply to F5U*, and, therefore, a new mechanism based on the idiosyncratic characteristics of F5U* must operate. The C–C glycosidic bond is shared with pseudouridine, so it is not a unique feature, but hydration both saturates the pyrimidine ring and introduces a hydroxyl group at C6. The fluoro group also dramatically changes the charge characteristics of the pyrimidine ring (Fig. 7). Saliently, C5 in F5U* bears a partial positive charge (+0.282) compared to a partial negative charge in uridine (−0.349) and pseudouridine (−0.202). The partial positive charge on C5 and the associated lengthening – and therefore – weakening – of the C4–C5 bond allows its easier cleavage.

Figure 7.

Figure 7

Natural bond order calculations show the different partial charges in the pyrimidine rings of (a) F5U*, (b) Ψ, and (c) U. For F5U*, R denotes the rest of the dinucleotide product (Fig. 2); for U and Ψ, R denotes ribose.

A mechanism that relies on the relative positioning of the hydroxyl group and charge distribution in F5U* leads to the loss of H–N1, C2, and O2 to generate a zwitterionic intermediate that can tautomerize to an aldehyde/amide or close to a β-lactam (Fig. 8). Formation of the zwitterion, 2, is likely facilitated by a hydrogen bond between the oxyanion end and the 2′-hydroxyl group of the trailing pyrimidine, for that stabilizing interaction is seen in the energy-minimized structure of the parent dinucleotide, 1 (Supplementary Fig. S3, see Supporting Information). These three candidate structures for the ions at 542 m/z were subjected to DFT energy minimization with unrestricted bond rotation, and the resulting energies (B3LYP electronic energy + AM1 thermal enthalpy) of each fragment was summed with that of HCNO for comparison to the dinucleotide of F5U*, 1. The aldehyde/amide, 3, was calculated to be 12.5 kcal/mol higher in energy than 1. During minimization, the zwitterion, 2, collapsed to the β-lactam, 4, which was calculated to be 26.5 kcal/mol higher than the dinucleotide of F5U*. Extrusion of O4, C4, and N3–H by homolysis of the C5–C4 and N3–C2 bonds was also considered and results in a diradical that collapses during minimization to afford the β-lactam. These results favor the aldehyde/amide, 3, over the β-lactam if product formation is under thermodynamic control, but the fragmentation may well be under kinetic control so that β-lactam formation dominates.

Figure 8.

Figure 8

The proposed mechanism for facile HNCO loss from from F5U*, 1. The initial HNCO loss (A) leads to the zwitterion (2), which can tautomerize (B) to the aldehyde/amide (3) or close (C) to the β-lactam (4). 2 can extrude a second HNCO (D) to generate the enol (5), as can 3 (E). 4 can fragment to afford 5, either by a pericyclic process (F) or by a mechanism (G) made possible by the relative disposition of the hydroxyl and fluoro groups (which formally yields the zwitterionic resonance form of 5). R denotes the rest of the dinucleotide product (Fig. 2).

In the next round of MSn, the β-lactam can extrude HNCO, perhaps in a pericyclic process comparable to the formation of the “B” fragments during MS of β-lactam antibiotics[22]b or by a mechanism allowed by the novel combination of β-hydroxyl and α-fluoro groups (Fig. 8). Alternatively, the β-lactam may reversibly form the zwitterion, which can fragment with the release of HNCO (Fig. 8). Based on the similar onsets of HNCO loss and phosphodiester cleavage in the energy-resolved CID plots, it is reasonable to conclude that both proceed through transition states of comparable energy, but the preponderance of fragments with HNCO loss indicates that the difference in transition state heights for the two processes is significant. Detailed assessment of these issues will require RRKM calculations to determine the exact transition states for each, which lies beyond the scope of this communication. Ion spectroscopy[24,25] would also be a powerful tool for the elucidation of this system, for the plausible fragmentation products were subjected to DFT vibrational frequency calculations, which indicate that the candidate products would be readily differentiated by their IR spectra (Supplementary Fig. S4, see Supporting Information), specifically in the carbonyl stretching region.

CONCLUSIONS

The fragmentation of the pyrimidine ring in F5U* is strikingly facile, with loss of HNCO occurring in-source and more readily than phosphodiester bond cleavage. Although HNCO loss is observed with uridine and pseudouridine, the retro-Diels-Alder mechanism that operates with these unsaturated pyrimidines cannot hold for the saturated pyrimidine ring of F5U*. A plausible mechanism that relies on the unique relative disposition of functional groups in F5U* nicely accounts for the observed HNCO loss but must be verified.

Supplementary Material

supplemental

Acknowledgments

The authors acknowledge the NIH for support through grant GM-59636 from NIGMS and through the ARRA-funded supplement GM-59636S1 (both to E.G.M) as well as the Commonwealth of Kentucky Research Challenge Trust Fund (‘Bucks for Brains’) and the Charles L. Bloch, M.D. Professorship. The authors also acknowledge the support of the Center for Regulatory and Analytical Metabolomics (CREAM) mass spectrometry facility, funded by NSF/EPSCoR grant EPS-0447479. We thank T. H. Morton for insightful discussions and suggestions regarding the fragmentation.

Footnotes

a

It is possible that the reported fragmentation pattern arises from markedly different contributions from each isomeric product. However, there is no evidence for the differential fragmentation of the identical pyrimidine ring of F5U* in the two products, and such differential fragmentation would not strongly affect the thrust of the results and conclusions.

b

The pericyclic fragmentation of β-lactam antibiotics to give a ketene product is established,[23] but the process proposed here for HNCO extrusion is not. However, such pericyclic cleavage of the antibiotics would not result in a change of mass because the nitrogen of the β-lactam is doubly substituted and so generates RNCO (where R represents the remaining atoms of the antibiotic), so the proposed pericyclic cleavage pathway would only become detectable upon further fragmentation, such as those seen for the “B” ions.[22]

SUPPORTING INFORMATION

Supporting information can be found in the online version of this article.

References

  • 1.Cohn WE. Pseudouridine, a carbon-carbon linked ribonucleoside in ribonucleic acids: isolation, structure, and chemical characteristics. J Biol Chem. 1960;235:1488. [PubMed] [Google Scholar]
  • 2.Mueller EG, Ferré-D’Amaré AR. In: DNA and RNA Modification Enzymes: Structure, Mechanism, Function and Evolution. Grosjean H, editor. Landes Bioscience; Austin: 2009. pp. 363–376. [Google Scholar]
  • 3.Gu X, Liu Y, Santi DV. The mechanism of pseudouridine synthase I as deduced from its interaction with 5-fluorouracil-tRNA. Proc Natl Acad Sci USA. 1999;96:14270. doi: 10.1073/pnas.96.25.14270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Spedaliere CJ, Ginter JM, Johnston MV, Mueller EG. The pseudouridine synthases: revisiting a mechanism that seemed settled. J Am Chem Soc. 2004;126:12758. doi: 10.1021/ja046375s. [DOI] [PubMed] [Google Scholar]
  • 5.Spedaliere CJ, Mueller EG. Not all pseudouridine synthases are potently inhibited by RNA containing 5-fluorouridine. RNA. 2004;10:192. doi: 10.1261/rna.5100104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hamilton CS, Greco TM, Vizthum CA, Ginter JM, Johnston MV, Mueller EG. Mechanistic investigations of the pseudouridine synthase RluA using RNA containing 5-fluorouridine. Biochemistry. 2006;45:12029. doi: 10.1021/bi061293x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McDonald MK, Miracco EJ, Chen J, Xie Y, Mueller EG. The handling of the mechanistic probe 5-fluorouridine by the pseudouridine synthase TruA and its consistency with the handling of the same probe by the pseudouridine synthases TruB and RluA. Biochemistry. 2011;50:426. doi: 10.1021/bi101737z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hoang C, Ferré-D’Amaré AR. Cocrystal structure of a tRNA–55 pseudouridine synthase: nucleotide flipping by an RNA-modifying enzyme. Cell. 2001;107:929. doi: 10.1016/s0092-8674(01)00618-3. [DOI] [PubMed] [Google Scholar]
  • 9.Miracco EJ, Mueller EG. The products of 5-fluorouridine by the action of the pseudouridine synthase TruB disfavor one mechanism and suggest another. J Am Chem Soc. 2011;133:11826. doi: 10.1021/ja201179f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McLuckey SA, Van Berker GJ, Glish GL. Tandem mass spectrometry of small, multiply charged oligonucleotides. J Am Soc Mass Spectrom. 1992;3:60. doi: 10.1016/1044-0305(92)85019-G. [DOI] [PubMed] [Google Scholar]
  • 11.Phillips DR, McCloskey JA. A comprehensive study of the low energy collision-induced dissociation of dinucleoside monophosphates. Int J Mass Spectrom Ion Processes. 1993;128:61. [Google Scholar]
  • 12.Kirpekar F, Krogh TN. RNA fragmentation studied in a matrix-assisted laser desorption/ionisation tandem quadrupole/orthogonal time-of-flight mass spectrometer. Rapid Commun Mass Spectrom. 2001;15:8. doi: 10.1002/1097-0231(20010115)15:1<8::AID-RCM185>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 13.Rice JM, Dudek GO, Barber M. Mass spectra of nucleic acid derivatives. Pyrimidines. J Am Chem Soc. 1965;87:4569. doi: 10.1021/ja00948a029. [DOI] [PubMed] [Google Scholar]
  • 14.Rice JM, Dudek GO. Mass spectra of uridine and pseudouridine: fragmentation patterns characteristic of a carbon-carbon nucleosidic bond. Biochem Biophys Res Commun. 1969;35:383. doi: 10.1016/0006-291x(69)90510-5. [DOI] [PubMed] [Google Scholar]
  • 15.Jankowska J, Golankiewicz B, Golankiewicz K. Further investigation of the mass fragmentation of dinucleotide analogues containing the 6-azauracil moiety. Org Mass Spectrom. 1984;19:143. [Google Scholar]
  • 16.Dudley E, Tuytten R, Bond A, Lemière F, Brenton AG, Esmans EL, Newton RP. Study of the mass spectrometric fragmentation of pseudouridine: comparison of fragmentation data obtained by matrix-assisted laser desorption/ionisation post-source decay, electrospray ion trap multistage mass spectrometry, and by a method utilising electrospray quadrupole time-of-flight tandem mass spectrometry and in-source fragmentation. Rapid Commun Mass Spectrom. 2005;19:3075. doi: 10.1002/rcm.2151. [DOI] [PubMed] [Google Scholar]
  • 17.Cao H, Wang Y. Collisionally activated dissociation of protonated 2′-deoxycytidine, 2′-deoxyuridine, and their oxidatively damaged derivatives. J Am Soc Mass Spectrom. 2006;17:1335. doi: 10.1016/j.jasms.2006.05.019. [DOI] [PubMed] [Google Scholar]
  • 18.Kamel AM, Munson B. Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry. J Am Soc Mass Spectrom. 2007;18:1477. doi: 10.1016/j.jasms.2007.05.001. [DOI] [PubMed] [Google Scholar]
  • 19.Ramamurthy V, Swann SL, Paulson JL, Spedaliere CJ, Mueller EG. Critical aspartic acid residues in pseudouridine synthases. J Biol Chem. 1999;274:22225. doi: 10.1074/jbc.274.32.22225. [DOI] [PubMed] [Google Scholar]
  • 20.Ramamurthy V, Swann SL, Spedaliere CJ, Mueller EG. Role of cysteine residues in pseudouridine synthases of different families. Biochemistry. 1999;38:13106. doi: 10.1021/bi9913911. [DOI] [PubMed] [Google Scholar]
  • 21.Hoang C, Chen J, Vizthum CA, Kandel JM, Hamilton CS, Mueller EG, Ferré-D’Amaré AR. Crystal structure of pseudouridine synthase RluA: indirect sequence readout through protein-induced RNA structure. Mol Cell. 2006;24:535. doi: 10.1016/j.molcel.2006.09.017. [DOI] [PubMed] [Google Scholar]
  • 22.Chong XM, Hu CQ. Compilation of an ESI-MS library of β-lactam antibiotics for rapid identification of drugs. Chromatographia. 2008;68:759. [Google Scholar]
  • 23.Mitscher LA, Showalter HDH, Shirahata K, Foltz RL. Chemical-ionization mass spectrometry of β-lactam antibiotics. J Antibiot. 1975;28:668. doi: 10.7164/antibiotics.28.668. [DOI] [PubMed] [Google Scholar]
  • 24.Duncan MA. Frontiers in the spectroscopy of mass-selected molecular ions. Int J Mass Spectrom. 2000;200:545. [Google Scholar]
  • 25.Baer T, Dunbar RC. Ion spectroscopy: where did it come from; where is it now; and where is it going? J Am Soc Mass Spectrom. 2010;21:681. doi: 10.1016/j.jasms.2010.01.028. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplemental

RESOURCES